FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076556247> ?p ?o ?g. }

• W2076556247 endingPage "P153" @default.
• W2076556247 startingPage "P153" @default.
• W2076556247 abstract "This article was originally published online on 23 April 2013 TRAIL is present in cells involved in asthma including eosinophils, mast cells, fibroblasts, and airway epithelial cells. It is expressed in airway remodeling and may be linked with the pathways of transforming growth factor-beta1, which is thought to cause damage to the epithelium. The repair process of the epithelium is hindered as a result of increased apoptosis induced by TGF-beta1, which overlaps with the pathways of TRAIL. Analogs of TRAIL could have therapeutical applications for asthma. TRAIL is also seen as the basis for a miracle drug for cancer because of its ability to selectively kill cancer cells. Allergic rhinitis is a common health problem affecting the immune system. The homeostasis of the immune system is regulated by apoptosis. In this study, serumcirculating soluble TRAIL levels of allergic rhinoconjunctivitis patients before allergen-specific immunotherapy and after the treatment was evaluated. Subjects with kidney disease, heart disease, liver disease, diabetes mellitus, cancer status, obesity, (body mass index (BMI) ≥30 kg.m2) and autoimmune disease were excluded clinically and serologically. The sTRAIL levels of pre- and post-treated allergic rhinoconjunctivitis patients (n=25) were compared to age and sex-matched healthy individuals (n=25). sTRAIL levels were measured by ELISA. The skin prick test (SPT) were recorded before and after treatment. The sTRAIL levels between the pre-treated and control groups were significantly different (p < 0,0001). However, there was no significant difference between post-treated group and healthy individuals (p = 0,801). SPT was a statistically significant difference between the values of the research group before and after immunotherapy (Grasses mixture, Barley mixture, Oleaauropeae, D. Pteronyssinus, D. farinae). Allergen- spesific immunotherapy treatment significantly reduced the nasal symptom score across all group I patients studied. In this study, SPT was a statistically significant difference between the values of the research group before and after immunotherapy (Grasses mixture, Barley mixture, Oleaauropeae, D.Pteronyssinus, D. farinae). The sTRAIL levels were decreased after allergen-specific immunotherapy as to healthy individuals’ levels. be a marker of efficacy of immunotherapy in allergic rhinoconjunctivitis patients." @default.
• W2076556247 created "2016-06-24" @default.
• W2076556247 creator A5014233084 @default.
• W2076556247 creator A5022539119 @default.
• W2076556247 creator A5054508746 @default.
• W2076556247 date "2013-01-01" @default.
• W2076556247 modified "2023-10-16" @default.
• W2076556247 title "Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy" @default.
• W2076556247 doi "https://doi.org/10.1186/1939-4551-6-s1-p153" @default.
• W2076556247 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3643244" @default.
• W2076556247 hasPublicationYear "2013" @default.
• W2076556247 type Work @default.
• W2076556247 sameAs 2076556247 @default.
• W2076556247 citedByCount "0" @default.
• W2076556247 crossrefType "journal-article" @default.
• W2076556247 hasAuthorship W2076556247A5014233084 @default.
• W2076556247 hasAuthorship W2076556247A5022539119 @default.
• W2076556247 hasAuthorship W2076556247A5054508746 @default.
• W2076556247 hasBestOaLocation W20765562471 @default.
• W2076556247 hasConcept C121608353 @default.
• W2076556247 hasConcept C126322002 @default.
• W2076556247 hasConcept C203014093 @default.
• W2076556247 hasConcept C207480886 @default.
• W2076556247 hasConcept C2776042228 @default.
• W2076556247 hasConcept C2777701055 @default.
• W2076556247 hasConcept C2779787640 @default.
• W2076556247 hasConcept C71924100 @default.
• W2076556247 hasConcept C8891405 @default.
• W2076556247 hasConceptScore W2076556247C121608353 @default.
• W2076556247 hasConceptScore W2076556247C126322002 @default.
• W2076556247 hasConceptScore W2076556247C203014093 @default.
• W2076556247 hasConceptScore W2076556247C207480886 @default.
• W2076556247 hasConceptScore W2076556247C2776042228 @default.
• W2076556247 hasConceptScore W2076556247C2777701055 @default.
• W2076556247 hasConceptScore W2076556247C2779787640 @default.
• W2076556247 hasConceptScore W2076556247C71924100 @default.
• W2076556247 hasConceptScore W2076556247C8891405 @default.
• W2076556247 hasLocation W20765562471 @default.
• W2076556247 hasLocation W20765562472 @default.
• W2076556247 hasLocation W20765562473 @default.
• W2076556247 hasOpenAccess W2076556247 @default.
• W2076556247 hasPrimaryLocation W20765562471 @default.
• W2076556247 hasRelatedWork W1490916211 @default.
• W2076556247 hasRelatedWork W1526272313 @default.
• W2076556247 hasRelatedWork W1986962886 @default.
• W2076556247 hasRelatedWork W2026887388 @default.
• W2076556247 hasRelatedWork W2048656548 @default.
• W2076556247 hasRelatedWork W2063526650 @default.
• W2076556247 hasRelatedWork W2079900469 @default.
• W2076556247 hasRelatedWork W2150194420 @default.
• W2076556247 hasRelatedWork W2985921288 @default.
• W2076556247 hasRelatedWork W30803436 @default.
• W2076556247 hasVolume "6" @default.
• W2076556247 isParatext "false" @default.
• W2076556247 isRetracted "false" @default.
• W2076556247 magId "2076556247" @default.
• W2076556247 workType "article" @default.